$350.00 tops. Conmed has GPO's but with Ligasure out there 13 years with multiple sealing devices, Conmed will have to play the price game .... again. Since Lig V is going for $420 on contracts, Conmed will play even better at $300 IF (big IF) they go after the 80% volume of lap colorectal/GYN and show equilvalent efficacy. The problem becomes profitability.
Covidien, Gyrus / Olympus and EnSeal (Ethicon) have "touched" 80% of the market and the majority use vessel sealing in some form. There are 250+ Ligasure reps. Add in EnSeal and Gyrus, and we're talking feet on the street. Intuitive will enter this crowded "space" too (although they've a captive market) making Conmed's barriers to entry even higher. On top of these market facts and barriers to entry, Conmed will have to give away free capital to get users. Free capital, on top of lower pricing at lower volumes relative to Ligasure (for instance), will continue to contribute to crappy margins for Conmed into the foreseeable future. Corasanti said at $10M in volume, they're losing money. He was assuming equal pricing and capital sales.
This entry, 13 years late, looks doomed.